Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2011

01.10.2011

Monozygotic Twin Pair Showing Discordant Phenotype for X-linked Thrombocytopenia and Wiskott–Aldrich Syndrome: a Role for Epigenetics?

verfasst von: David Buchbinder, Kari Nadeau, Diane Nugent

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Despite our increasing characterization of the molecular basis for many primary immunodeficiency states, significant heterogeneity in clinical and immunological phenotype exists. Epigenetic alterations have been implicated in the pathogenesis of immune dysregulation and may provide a unique paradigm to help us understand the phenotypic heterogeneity in primary immunodeficiency. The occurrence of X-linked thrombocytopenia (XLT) and Wiskott–Aldrich syndrome (WAS) in monozygotic twins is a rare occurrence which allows for the exploration of epigenetic alterations and associated phenotypic heterogeneity. We describe a pair of monozygotic twin brothers with a missense mutation in the WAS gene consistent with reduced expression of the WAS protein, a XLT phenotype, and a good prognosis. Despite this genotype and anticipated mild phenotype in both twins, a discordant phenotype has evolved in which one twin demonstrates asymptomatic thrombocytopenia and the other symptomatic thrombocytopenia, infectious complications, and autoimmunity. Characterization of the potential epigenetic contribution to the spectrum of XLT and WAS is described and the implications of these findings are discussed.
Literatur
1.
2.
Zurück zum Zitat Lim MS, Elenitoba-Johnson K. The molecular pathology of primary immunodeficiencies. J Mol Diagn. 2004;6:59–83.PubMedCrossRef Lim MS, Elenitoba-Johnson K. The molecular pathology of primary immunodeficiencies. J Mol Diagn. 2004;6:59–83.PubMedCrossRef
3.
Zurück zum Zitat Morange M. The relations between genetics and epigenetics: a historical point of view. Ann N Y Acad Sci. 2002;981:50–60.PubMedCrossRef Morange M. The relations between genetics and epigenetics: a historical point of view. Ann N Y Acad Sci. 2002;981:50–60.PubMedCrossRef
4.
Zurück zum Zitat Holiday R. Epigenetics: a historical overview. Epigenetics. 2006;1:76–80.CrossRef Holiday R. Epigenetics: a historical overview. Epigenetics. 2006;1:76–80.CrossRef
5.
Zurück zum Zitat Geha RS, Notarangelo LD, Casanova J-L, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.PubMedCrossRef Geha RS, Notarangelo LD, Casanova J-L, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.PubMedCrossRef
6.
Zurück zum Zitat Buckley RH. Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest. 2005;115:2974–6.PubMedCrossRef Buckley RH. Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest. 2005;115:2974–6.PubMedCrossRef
7.
Zurück zum Zitat Meda F, Folci M, Baccarelli A, et al. The epigenetics of autoimmunity. Cell Mol Immunol. 2011;8:226–36.PubMedCrossRef Meda F, Folci M, Baccarelli A, et al. The epigenetics of autoimmunity. Cell Mol Immunol. 2011;8:226–36.PubMedCrossRef
8.
Zurück zum Zitat Hewagama A, Richardson B. The genetics and epigenetics of autoimmune disease. J Autoimmun. 2009;33:3–11.PubMedCrossRef Hewagama A, Richardson B. The genetics and epigenetics of autoimmune disease. J Autoimmun. 2009;33:3–11.PubMedCrossRef
9.
Zurück zum Zitat Erlich M, Sanchez C, Shao C, et al. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 2008;41:253–71.CrossRef Erlich M, Sanchez C, Shao C, et al. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 2008;41:253–71.CrossRef
10.
Zurück zum Zitat Erlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol. 2003;109:17–28.CrossRef Erlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol. 2003;109:17–28.CrossRef
11.
Zurück zum Zitat Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott–Aldrich syndrome. Blood. 2009;113:6288–95.PubMedCrossRef Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott–Aldrich syndrome. Blood. 2009;113:6288–95.PubMedCrossRef
12.
Zurück zum Zitat Ochs HD, Filipovich AH, Veys P, et al. Wiskott–Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15:84–90.PubMedCrossRef Ochs HD, Filipovich AH, Veys P, et al. Wiskott–Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15:84–90.PubMedCrossRef
13.
Zurück zum Zitat Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115:3231–8.PubMedCrossRef Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115:3231–8.PubMedCrossRef
14.
Zurück zum Zitat Gulacsy V, Freiberger T, Shcherbina A, et al. Genetic characteristics of eighty-seven patients with the Wiskott–Aldrich syndrome. Mol Immunol. 2011;48:788–92.PubMedCrossRef Gulacsy V, Freiberger T, Shcherbina A, et al. Genetic characteristics of eighty-seven patients with the Wiskott–Aldrich syndrome. Mol Immunol. 2011;48:788–92.PubMedCrossRef
15.
Zurück zum Zitat Thompson LJ, Lalloz M, Layton DM. Unique and recurrent WAS gene mutation in Wiskott–Aldrich syndrome and X-linked thrombocytopenia. Blood Cells Mol Dis. 1999;25:218–26.PubMedCrossRef Thompson LJ, Lalloz M, Layton DM. Unique and recurrent WAS gene mutation in Wiskott–Aldrich syndrome and X-linked thrombocytopenia. Blood Cells Mol Dis. 1999;25:218–26.PubMedCrossRef
16.
Zurück zum Zitat Zhu Q, Watanabe C, Liu T, et al. Wiskott–Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997;90:2680–9.PubMed Zhu Q, Watanabe C, Liu T, et al. Wiskott–Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997;90:2680–9.PubMed
17.
Zurück zum Zitat Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott–Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.PubMedCrossRef Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott–Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.PubMedCrossRef
18.
Zurück zum Zitat Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456–64.PubMedCrossRef Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456–64.PubMedCrossRef
19.
Zurück zum Zitat Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott–Aldrich syndrome: no strict genotype–phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98:68–76.PubMedCrossRef Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott–Aldrich syndrome: no strict genotype–phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98:68–76.PubMedCrossRef
20.
Zurück zum Zitat Fillat C, Espanol T, Oset M, et al. Identification of WASP mutations in 14 Spanish families with Wiskott–Aldrich syndrome. Am J Med Genet. 2001;100:116–21.PubMedCrossRef Fillat C, Espanol T, Oset M, et al. Identification of WASP mutations in 14 Spanish families with Wiskott–Aldrich syndrome. Am J Med Genet. 2001;100:116–21.PubMedCrossRef
21.
Zurück zum Zitat Yu GP, Chiang D, Song SJ, et al. Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol. 2009;131:240–53.PubMedCrossRef Yu GP, Chiang D, Song SJ, et al. Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol. 2009;131:240–53.PubMedCrossRef
22.
Zurück zum Zitat Nadeau KC, Callejas A, Wong WB, et al. Idiopathic neutropenia of childhood is associated with Fas/FasL expression. Clin Immunol. 2008;129:438–47.PubMedCrossRef Nadeau KC, Callejas A, Wong WB, et al. Idiopathic neutropenia of childhood is associated with Fas/FasL expression. Clin Immunol. 2008;129:438–47.PubMedCrossRef
23.
Zurück zum Zitat Nguyen KD, Vanichsarn C, Fohner A, et al. Selective deregulation in chemokine signaling pathways of CD4 + CD25(hi)CD127(lo)/(−) regulatory T cells in human allergic asthma. J Allergy Clin Immunol. 2009;123:933–9.PubMedCrossRef Nguyen KD, Vanichsarn C, Fohner A, et al. Selective deregulation in chemokine signaling pathways of CD4 + CD25(hi)CD127(lo)/(−) regulatory T cells in human allergic asthma. J Allergy Clin Immunol. 2009;123:933–9.PubMedCrossRef
24.
Zurück zum Zitat Forsyth K, Seshadri R, Matthews C, Heddle R. Wiskott–Aldrich in identical twins: abnormality of CD4 and CD8 positive lymphocytes. Aust NZ J Med. 1988;18:73–6.CrossRef Forsyth K, Seshadri R, Matthews C, Heddle R. Wiskott–Aldrich in identical twins: abnormality of CD4 and CD8 positive lymphocytes. Aust NZ J Med. 1988;18:73–6.CrossRef
25.
Zurück zum Zitat Xie H, Wang M, de Andrade A, et al. Genome-wide quantitative assessment of variation in DNA methylation patterns. Nucleic Acids Res. 2011;39:4099–108.PubMedCrossRef Xie H, Wang M, de Andrade A, et al. Genome-wide quantitative assessment of variation in DNA methylation patterns. Nucleic Acids Res. 2011;39:4099–108.PubMedCrossRef
26.
Zurück zum Zitat Ushijima T, Watanabe N, Okochi E, et al. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 2003;13:868–74.PubMedCrossRef Ushijima T, Watanabe N, Okochi E, et al. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 2003;13:868–74.PubMedCrossRef
27.
Zurück zum Zitat Pearce EL. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev. 2006;211:197–202.PubMedCrossRef Pearce EL. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev. 2006;211:197–202.PubMedCrossRef
28.
Zurück zum Zitat McCall CE, Yoza B, Liu T, et al. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J Innate Immun. 2010;2:395–405.PubMedCrossRef McCall CE, Yoza B, Liu T, et al. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J Innate Immun. 2010;2:395–405.PubMedCrossRef
29.
Zurück zum Zitat Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009;73:770–80.PubMedCrossRef Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009;73:770–80.PubMedCrossRef
30.
Zurück zum Zitat Copeland RA, Olhava EJ, Scott MP. Targeting epigenetic enzymes for drug discovery. Curr Opin Chem Biol. 2010;14:505–10.PubMedCrossRef Copeland RA, Olhava EJ, Scott MP. Targeting epigenetic enzymes for drug discovery. Curr Opin Chem Biol. 2010;14:505–10.PubMedCrossRef
31.
Zurück zum Zitat Mack GS. Epigenetic cancer therapy makes headway. JNCI. 2006;98:1443–4.PubMed Mack GS. Epigenetic cancer therapy makes headway. JNCI. 2006;98:1443–4.PubMed
Metadaten
Titel
Monozygotic Twin Pair Showing Discordant Phenotype for X-linked Thrombocytopenia and Wiskott–Aldrich Syndrome: a Role for Epigenetics?
verfasst von
David Buchbinder
Kari Nadeau
Diane Nugent
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2011
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9561-3

Weitere Artikel der Ausgabe 5/2011

Journal of Clinical Immunology 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.